Enhanced Mitochondrial Viability via Engineered Hyrdogels for Intrathecal Spinal Cord Delivery
通过用于鞘内脊髓输送的工程水凝胶增强线粒体活力
基本信息
- 批准号:10447178
- 负责人:
- 金额:$ 44.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-30 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AcuteAntioxidantsBiochemicalBioenergeticsCell CountCellsConfocal MicroscopyCytosolDevelopmentDiffuseDoseEngineeringEnvironmentFosteringFunctional disorderGelGlutathioneHealthHistologicHomeostasisHyaluronic AcidHydrogelsHypersensitivityIn VitroInflammatoryInjectableInjuryInterventionIntrathecal InjectionsKineticsKnowledgeLabelLevocarnitine AcetylLocomotionMaintenanceMechanicsMethylcelluloseMitochondriaMolecular ChaperonesMuscle MitochondriaN-AcetylcysteinamideOrganellesOsmotic PressureOutcome MeasureOxidative StressPC12 CellsPharmacologic SubstancePolymersProductionPropertyProteinsRattusRecovery of FunctionReportingResearchRouteSiteSoleus MuscleSpinal CordSpinal Cord ContusionsSpinal InjectionsSpinal cord injurySystemTestingTherapeutic InterventionTimeTissuesTransplantationbasecell injurycombinatorialdesigndosageexperimental studyextracellularfunctional outcomesimprovedin vivoin vivo evaluationinjuredinnovationinsightmitochondrial dysfunctionneuroprotectionnovelpreservationuptake
项目摘要
Project Summary/Abstract
Mitochondrial dysfunction is pivotal to the neuropathological sequelae following traumatic spinal cord
injury (SCI). During this initial time window, there is a significant loss of mitochondria with an
inflammatory/oxidative environment that perpetuates the pathophysiology. It is hypothesized that to
rescue the cellular damage occurring following SCI, one must replace damaged mitochondria, while also
changing the damaging microenvironment. We have documented that maintaining endogenous
mitochondrial bioenergetics with acetyl-l-carnitine (ALC), an alternative mitochondrial biofuel, or reducing
oxidative stress by replenishing endogenous antioxidant, glutathione (GSH) with N-acetylcysteine amide
(NACA) after SCI results in increased, but limited long-term functional neuroprotection. We have also
reported that acute mitochondrial transplantation (MitoTxp) using intraspinal injections of mitochondria
isolated from rat soleus muscle significantly preserved bioenergetic function 48hr post-SCI. However,
this was sporadically successful due to the challenges of both accumulating mitochondria at the site of
injury and maintaining their viability prior to cellular uptake. In the current proposal, we will develop a
thermo-gelling, erodible hydrogel system for the localized delivery of viable mitochondria to test the
neuroprotective efficacy of combined MitoTxp and pharmaceutical interventions (ALC and/or NACA) after
contusion SCI. The use of an injectable hydrogel will permit the development of a local environment which
can aide in maintaining mitochondrial health through optimization of the hydrogel niche. We will determine
1) optimum constituents for isolated mitochondria to remain viable for extended periods in polymeric
hydrogels, 2) whether exogenous mitochondria transplanted via less invasive intrathecal route equally
preserve integrity of bioenergetics compared to intraspinal route and 3) consequences of acute or
delayed MitoTxp in combination with ALC and/or NACA on bioenergetics, oxidative stress, and functional
neuroprotection after SCI.
项目摘要/摘要
线粒体功能障碍是创伤性脊髓后神经病理后遗症的关键
受伤(SCI)。在此初始时间窗口中,线粒体显着损失
炎症/氧化环境使病理生理延续。假设
挽救SCI后发生的细胞损伤,必须替换受损的线粒体,同时也必须
改变有害的微环境。我们已经记录了维持内源性的
用乙酰基-L-肉碱(ALC),一种替代性线粒体生物燃料或还原的线粒体生物能学
通过与N-乙酰半胱氨酸酰胺补充内源性抗氧化剂(GSH),通过补充内源性抗氧化剂(GSH)来氧化应激
(NACA)在SCI后导致增加,但长期功能神经保护有限。我们也有
报道了使用线粒体内注射急性线粒体移植(MITOTXP)
从大鼠肌肉中分离出明显保存的生物能功能48小时后。然而,
由于两者都在地点积累线粒体的挑战,这在偶尔会取得成功
损伤并保持细胞摄取之前的生存能力。在当前的建议中,我们将开发
热螺旋,可侵蚀的水凝胶系统,用于局部递送可行的线粒体,以测试
MITOTXP和药物干预措施(ALC和/或NACA)的神经保护功效
挫伤科学。使用可注射水凝胶将允许开发当地环境
可以通过优化水凝胶生殖位来帮助维持线粒体健康。我们将确定
1)隔离线粒体的最佳成分可在聚合物中长时间保持生存
水凝胶,2)外源线粒体是否通过侵入性鞘内较少的途径移植
与主途径相比,保持生物能学的完整性和3)急性或
延迟MitoTXP与ALC和/或NACA结合使用生物能,氧化应激和功能
科学后的神经保护。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Samirkumar Patel其他文献
Samirkumar Patel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Samirkumar Patel', 18)}}的其他基金
Safety and Tolerability of TASIS-Peanut (Targeted Allergen Specific Immunotherapy within the Skin) patch for the Treatment of Peanut Allergy
TASIS-花生(皮肤内靶向过敏原特异性免疫疗法)贴剂治疗花生过敏的安全性和耐受性
- 批准号:
10551184 - 财政年份:2023
- 资助金额:
$ 44.99万 - 项目类别:
Development of a Novel Animal Model for Spinal Cord Injury with Sepsis
脓毒症脊髓损伤新型动物模型的开发
- 批准号:
10665862 - 财政年份:2023
- 资助金额:
$ 44.99万 - 项目类别:
Enhanced Mitochondrial Viability via Engineered Hyrdogels for Intrathecal Spinal Cord Delivery
通过用于鞘内脊髓输送的工程水凝胶增强线粒体活力
- 批准号:
10647848 - 财政年份:2020
- 资助金额:
$ 44.99万 - 项目类别:
Enhanced Mitochondrial Viability via Engineered Hyrdogels for Intrathecal Spinal Cord Delivery
通过用于鞘内脊髓输送的工程水凝胶增强线粒体活力
- 批准号:
10093663 - 财政年份:2020
- 资助金额:
$ 44.99万 - 项目类别:
Enhanced Mitochondrial Viability via Engineered Hyrdogels for Intrathecal Spinal Cord Delivery
通过用于鞘内脊髓输送的工程水凝胶增强线粒体活力
- 批准号:
10266098 - 财政年份:2020
- 资助金额:
$ 44.99万 - 项目类别:
Microneedle Based Targeted Allergen Specific Immunotherapy for Treatment of Peanut Allergies
基于微针的靶向过敏原特异性免疫疗法治疗花生过敏
- 批准号:
10368182 - 财政年份:2019
- 资助金额:
$ 44.99万 - 项目类别:
Microneedle Based Targeted Allergen Specific Immunotherapy for Treatment of Peanut Allergies
基于微针的靶向过敏原特异性免疫疗法治疗花生过敏
- 批准号:
9899934 - 财政年份:2019
- 资助金额:
$ 44.99万 - 项目类别:
Microneedle Based Targeted Allergen Specific Immunotherapy for Treatment of Peanut Allergies
基于微针的靶向过敏原特异性免疫疗法治疗花生过敏
- 批准号:
10407661 - 财政年份:2019
- 资助金额:
$ 44.99万 - 项目类别:
相似国自然基金
抗氧化剂/活性离子时序释放复合支架构建及其修复糖尿病骨缺损的机制研究
- 批准号:32360232
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
塑料抗氧化剂内分泌干扰转化产物的识别与环境行为研究
- 批准号:22306042
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
农用地膜抗氧化剂的土壤污染特征及其微生物效应与机制研究
- 批准号:42377223
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
自然水体轮胎抗氧化剂高毒醌类衍生物非靶向识别及生物转化机制
- 批准号:42377360
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
取代对苯二胺抗氧化剂及其醌衍生物的人体内暴露标志物研究
- 批准号:22306031
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Oxidative Lipidomics in Pediatric Traumatic Brain Injury
氧化脂质组学在小儿创伤性脑损伤中的应用
- 批准号:
10844023 - 财政年份:2023
- 资助金额:
$ 44.99万 - 项目类别:
Ferroptosis in knock-in sepiapterin reductase mutation rabbits
敲入墨蝶呤还原酶突变兔的铁死亡
- 批准号:
10747716 - 财政年份:2023
- 资助金额:
$ 44.99万 - 项目类别:
Exploiting Carbon Monoxide Biofoams to Radio-Sensitize Rectal Cancer Cells While Protecting Normal Bowel
利用一氧化碳生物泡沫对直肠癌细胞放射增敏,同时保护正常肠道
- 批准号:
10572013 - 财政年份:2023
- 资助金额:
$ 44.99万 - 项目类别:
Recombinant human CC10 protein for treatment and prevention of chronic lung allograft dysfunction
重组人 CC10 蛋白用于治疗和预防慢性同种异体肺移植功能障碍
- 批准号:
10602077 - 财政年份:2023
- 资助金额:
$ 44.99万 - 项目类别: